Literature DB >> 9284121

Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1.

F Qadri1, C Wennerås, M J Albert, J Hossain, K Mannoor, Y A Begum, G Mohi, M A Salam, R B Sack, A M Svennerholm.   

Abstract

Vibrio cholerae O139 has recently emerged as the second etiologic agent of cholera in Asia. A study was carried out to evaluate the induction of specific immune responses to the organism in V. cholerae O139-infected patients. The immune responses to V. cholerae O139 Bengal were studied in patients by measuring antibody-secreting cells (ASC), as well as vibriocidal and antitoxic antibodies in the circulation. These responses were compared with those in patients with V. cholerae O1 disease. Strong immunoglobulin A (IgA) and IgM ASC responses were seen against the homologous lipopolysaccharide or serogroup of V. cholerae. The magnitude and isotype of the responses were similar in O139- and O1-infected patients. Vibriocidal antibody responses were seen against bacteria of the homologous but not heterologous serogroup, and these responses reflect the lack of cross-protection between the infections caused by the two serogroups. The two groups of patients showed comparable cholera toxin-specific ASC responses, with the IgG isotype dominating over the IgA isotype, as well as comparable antitoxic immune responses in plasma. These results suggest that despite having a polysaccharide capsule, V. cholerae O139 induces systemic and intestine-derived ASC responses in peripheral blood comparable to those seen in patients with V. cholerae O1 disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284121      PMCID: PMC175508          DOI: 10.1128/iai.65.9.3571-3576.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences.

Authors:  J A Johnson; C A Salles; P Panigrahi; M J Albert; A C Wright; R J Johnson; J G Morris
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

2.  Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral immunization of rabbits with V. cholerae O1 vaccine strain CVD103-HgR.

Authors:  M J Albert; K Alam; M Ansaruzzaman; F Qadri; R B Sack
Journal:  J Infect Dis       Date:  1994-01       Impact factor: 5.226

3.  Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh.

Authors:  M J Albert; A K Siddique; M S Islam; A S Faruque; M Ansaruzzaman; S M Faruque; R B Sack
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

4.  Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers.

Authors:  J G Morris; G E Losonsky; J A Johnson; C O Tacket; J P Nataro; P Panigrahi; M M Levin
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

5.  Vibrio cholerae O139 Bengal possesses a capsular polysaccharide which may confer increased virulence.

Authors:  A Weintraub; G Widmalm; P E Jansson; M Jansson; K Hultenby; M J Albert
Journal:  Microb Pathog       Date:  1994-03       Impact factor: 3.738

6.  Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype.

Authors:  T S Coster; K P Killeen; M K Waldor; D T Beattie; D R Spriggs; J R Kenner; A Trofa; J C Sadoff; J J Mekalanos; D N Taylor
Journal:  Lancet       Date:  1995-04-15       Impact factor: 79.321

7.  The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants.

Authors:  M K Waldor; R Colwell; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

Review 8.  Induction and assessment of immunity at enteromucosal surfaces in humans: implications for vaccine development.

Authors:  C Czerkinsky; A M Svennerholm; J Holmgren
Journal:  Clin Infect Dis       Date:  1993-03       Impact factor: 9.079

9.  Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1.

Authors:  F Qadri; G Mohi; J Hossain; T Azim; A M Khan; M A Salam; R B Sack; M J Albert; A M Svennerholm
Journal:  Clin Diagn Lab Immunol       Date:  1995-11

10.  Production, characterization, and application of monoclonal antibodies to Vibrio cholerae O139 synonym Bengal.

Authors:  F Qadri; T Azim; A Chowdhury; J Hossain; R B Sack; M J Albert
Journal:  Clin Diagn Lab Immunol       Date:  1994-01
View more
  69 in total

1.  Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.

Authors:  Daniel T Leung; Mohammad Arif Rahman; M Mohasin; Sweta M Patel; Amena Aktar; Farhana Khanam; Taher Uddin; M Asrafuzzaman Riyadh; Amit Saha; Mohammad Murshid Alam; Fahima Chowdhury; Ashraful Islam Khan; Richelle Charles; Regina LaRocque; Jason B Harris; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

2.  Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice.

Authors:  Julianne E Rollenhagen; Anuj Kalsy; Rina Saksena; Alaullah Sheikh; Mohammad Murshid Alam; Firdausi Qadri; Stephen B Calderwood; Pavol Kovác; Edward T Ryan
Journal:  Vaccine       Date:  2009-06-27       Impact factor: 3.641

3.  Enterotoxin-specific immunoglobulin E responses in humans after infection or vaccination with diarrhea-causing enteropathogens.

Authors:  F Qadri; M Asaduzzaman; C Wennerås; G Mohi; M J Albert; M Abdus Salam; R B Sack; M Jertborn; J R McGhee; D A Sack; J Holmgren
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera.

Authors:  Mohammad Murshid Alam; M Asrafuzzaman Riyadh; Kaniz Fatema; Mohammad Arif Rahman; Nayeema Akhtar; Tanvir Ahmed; Mohiul Islam Chowdhury; Fahima Chowdhury; Stephen B Calderwood; Jason B Harris; Edward T Ryan; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2011-02-23

5.  Mucosal immunologic responses in cholera patients in Bangladesh.

Authors:  Taher Uddin; Jason B Harris; Taufiqur Rahman Bhuiyan; Tahmina Shirin; Muhammad Ikhtear Uddin; Ashraful Islam Khan; Fahima Chowdhury; Regina C LaRocque; Nur Haque Alam; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2011-01-19

6.  Origins of the current seventh cholera pandemic.

Authors:  Dalong Hu; Bin Liu; Lu Feng; Peng Ding; Xi Guo; Min Wang; Boyang Cao; Peter R Reeves; Lei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-14       Impact factor: 11.205

7.  Cholera caused by Vibrio cholerae O1 induces T-cell responses in the circulation.

Authors:  Taufiqur Rahman Bhuiyan; Samuel B Lundin; Ashraful Islam Khan; Anna Lundgren; Jason B Harris; Stephen B Calderwood; Firdausi Qadri
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

8.  Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut.

Authors:  F Qadri; T R Bhuiyan; K K Dutta; R Raqib; M S Alam; N H Alam; A-M Svennerholm; M M Mathan
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

9.  Intranasal bacteria induce Th1 but not Treg or Th2.

Authors:  M Costalonga; P P Cleary; L A Fischer; Z Zhao
Journal:  Mucosal Immunol       Date:  2008-10-08       Impact factor: 7.313

10.  Detection of antibodies to toxin-coregulated pili in sera from cholera patients.

Authors:  Stephen R Attridge; Gun Wallerström; Firdausi Qadri; Ann-Mari Svennerholm
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.